Kazia Therapeutics Limited
KZIA
$6.75
$0.172.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.73M | -18.20M | -17.58M | -13.97M | -10.41M |
| Total Depreciation and Amortization | 1.23M | 1.23M | 1.23M | 1.23M | 1.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.47M | 3.99M | 3.50M | 1.22M | -1.07M |
| Change in Net Operating Assets | 5.33M | 5.95M | 6.58M | 4.19M | 1.81M |
| Cash from Operations | -7.70M | -7.02M | -6.28M | -7.33M | -8.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -600.00 | 387.70K | 776.00K | 776.30K | 776.60K |
| Total Debt Repaid | 800.00 | -185.10K | -371.00K | -371.40K | -371.80K |
| Issuance of Common Stock | 11.03M | 8.49M | 5.96M | 9.07M | 12.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -55.80K | -216.20K | -376.60K | -549.10K | -721.60K |
| Cash from Financing | 7.25M | 5.62M | 3.92M | 5.89M | 7.92M |
| Foreign Exchange rate Adjustments | 129.10K | 69.20K | 8.30K | -900.00 | -9.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.60K | -1.33M | -2.35M | -1.44M | -521.80K |